Literature DB >> 19446658

Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.

Mattias Mild1, Anders Kvist, Joakim Esbjörnsson, Ingrid Karlsson, Eva Maria Fenyö, Patrik Medstrand.   

Abstract

The recent introduction of entry inhibitors in the clinic as components of antiretroviral treatment has heightened the interest in coreceptor use of human immunodeficiency virus type 1 (HIV-1). Viruses using CCR5 as coreceptor (R5 viruses) are generally present over the entire course of infection whereas viruses using the CXCR4 coreceptor (R5X4/X4 viruses) emerge in about 50% of infected individuals during later stages of infection. The CCR5-to-CXCR4 switch represents a concern because CCR5 inhibitors, while suppressing R5 viruses, may allow the emergence of CXCR4-tropic viruses. In this study, HIV-1 populations that maintained CCR5 usage during infection were compared with populations that switched coreceptor usage to include CXCR4 later during infection, with the aim to find molecular properties of the virus populations associated with the CCR5-to-CXCR4 switch. We amplified and molecularly cloned the V1-V3 region of the HIV-1 envelope from 51 sequential HIV-1 isolates derived from 4 to 10 serial samples for each of the patients. Four of the patients had virus populations that switched coreceptor usage to include CXCR4 (switch populations: SP) during infection and four patients had viral populations that maintained exclusive CCR5 usage (non-switch populations: nSP). Coreceptor usage was determined experimentally on individual clones from dualtropic R5X4 isolates. In nSP we found that the number of potential N-linked glycosylation sites (PNGS) increased over time, whereas no pattern of change was observed in SP. We also found differences in V2 length and V3 charge between R5 viruses of nSP and R5 viruses of SP before the switch. The V2 region was significantly longer in R5 viruses of SP compared to viruses of nSP throughout the course of infection, and the V3 charge increased with time in R5 populations from SP, while it remained unchanged or decreased in nSP. These molecular properties could prove important for understanding the evolution of coreceptor usage in HIV-1 populations, and maybe even for predicting an upcoming coreceptor switch at early stages after primary infection. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19446658     DOI: 10.1016/j.meegid.2009.05.003

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  17 in total

1.  Impact of mutations outside the V3 region on coreceptor tropism phenotypically assessed in patients infected with HIV-1 subtype B.

Authors:  Laura Monno; Annalisa Saracino; Luigia Scudeller; Grazia Punzi; Gaetano Brindicci; Maurantonio Altamura; Antonella Lagioia; Nicoletta Ladisa; Gioacchino Angarano
Journal:  Antimicrob Agents Chemother       Date:  2011-08-29       Impact factor: 5.191

2.  Is the rate of CD4 cell decline changing over time in antiretroviral-naïve patients?

Authors:  Daniela Cardeal da Silva; Jorge Casseb; Ali Mirzazadeh; Liã B Arruda; George W Rutherford
Journal:  AIDS Patient Care STDS       Date:  2013-01-08       Impact factor: 5.078

3.  High-Sequence Diversity and Rapid Virus Turnover Contribute to Higher Rates of Coreceptor Switching in Treatment-Experienced Subjects with HIV-1 Viremia.

Authors:  Rebecca Nedellec; Joshua T Herbeck; Peter W Hunt; Steven G Deeks; James I Mullins; Elizabeth D Anton; Jacqueline D Reeves; Donald E Mosier
Journal:  AIDS Res Hum Retroviruses       Date:  2016-10-12       Impact factor: 2.205

Review 4.  Molecular Mechanism of HIV-1 Entry.

Authors:  Bing Chen
Journal:  Trends Microbiol       Date:  2019-06-28       Impact factor: 17.079

5.  Evolution of HIV-1 coreceptor usage and coreceptor switching during pregnancy.

Authors:  Doris G Ransy; Alena Motorina; Natacha Merindol; Bertine S Akouamba; Johanne Samson; Yolanda Lie; Laura A Napolitano; Normand Lapointe; Marc Boucher; Hugo Soudeyns
Journal:  AIDS Res Hum Retroviruses       Date:  2013-10-25       Impact factor: 2.205

6.  Buffering deleterious polymorphisms in highly constrained parts of HIV-1 envelope by flexible regions.

Authors:  Romain Gasser; Meriem Hamoudi; Martina Pellicciotta; Zhicheng Zhou; Clara Visdeloup; Philippe Colin; Martine Braibant; Bernard Lagane; Matteo Negroni
Journal:  Retrovirology       Date:  2016-07-30       Impact factor: 4.602

Review 7.  Pathogenesis of HIV Infection.

Authors:  Hassan M Naif
Journal:  Infect Dis Rep       Date:  2013-06-06

8.  Frequency and predictors of HIV-1 co-receptor switch in treatment naive patients.

Authors:  Virginie Mortier; Kenny Dauwe; Leen Vancoillie; Delfien Staelens; Filip Van Wanzeele; Dirk Vogelaers; Linos Vandekerckhove; Kristen Chalmet; Chris Verhofstede
Journal:  PLoS One       Date:  2013-11-07       Impact factor: 3.240

9.  Determination of viral tropism by genotyping and phenotyping assays in Brazilian HIV-1-infected patients.

Authors:  Liã Bárbara Arruda; Marilia Ladeira de Araújo; Maira Luccia Martinez; Claudio Roberto Gonsalez; Alberto José da Silva Duarte; Eoin Coakley; Yolanda Lie; Jorge Casseb
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Jul-Aug       Impact factor: 1.846

Review 10.  Antibody Conjugates for Targeted Therapy Against HIV-1 as an Emerging Tool for HIV-1 Cure.

Authors:  Jeffrey C Umotoy; Steven W de Taeye
Journal:  Front Immunol       Date:  2021-07-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.